THEODORE ZUCCONI, PH.D.

Corporate Board Profile

Tech Score: 0/100

← Back to All Directors

GALECTIN THERAPEUTICS INC

Filing Date Source Excerpt
2016-11-10 The persons below have been nominated for election by the holder(s) of the Series B preferred stock voting as a separate class ... Theodore Zucconi, Ph.D. ... Age 70 ... Director Since n/a
2017-11-07 Theodore Zucconi, Ph.D. ... 70 2016 ... Series B Directors ... Theodore Zucconi and Arthur Greenberg are the members of the Investor Relations/Public Relations Committee ... Director Compensation: Theodore Zucconi, Ph.D. ... Total ($) 23,204
2018-04-11 Theodore Zucconi, Ph.D. ... The members of the Investor Relations/Public Relations Committee in 2017 ... Theodore Zucconi, Ph.D. ... Total ($) 126,617.

Source material: SEC submissions metadata and DEF 14A proxy filings from EDGAR. Last updated: 2026-05-06